Megan Ludwig

531 total citations
31 papers, 318 citations indexed

About

Megan Ludwig is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Megan Ludwig has authored 31 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Megan Ludwig's work include Cancer Genomics and Diagnostics (7 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). Megan Ludwig is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). Megan Ludwig collaborates with scholars based in United States, Germany and Ghana. Megan Ludwig's co-authors include J. Chad Brenner, Andrew C. Birkeland, Matthew E. Spector, Rebecca C. Hoesli, Paul Swiecicki, Nicole L. Michmerhuizen, Jacqueline E. Mann, Thomas E. Carey, Mark E. Prince and Hui Jiang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Megan Ludwig

28 papers receiving 315 citations

Peers

Countries citing papers authored by Megan Ludwig

Since Specialization

Citations

This map shows the geographic impact of Megan Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Ludwig more than expected).

Fields of papers citing papers by Megan Ludwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Ludwig. The network helps show where Megan Ludwig may publish in the future.

Co-authorship network of co-authors of Megan Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Ludwig. A scholar is included among the top collaborators of Megan Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Ludwig. Megan Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer 2025 ·Oncotarget ·(unknown), (unknown), (unknown), (unknown), Gaute Døhlen, (unknown), (unknown), (unknown), (unknown), Megan Ludwig, (unknown), (unknown), Hai Dang Nguyen, Scott M. Dehm, Justin M. Drake, Emmanuel S. Antonarakis, Justin H. Hwang	0
2	Integrated CTC- and EV-based detection of PSMA protein and efficacy of ¹⁷⁷ Lu-PSMA-617 radioligand therapy. 2025 ·Journal of Clinical Oncology ·(unknown), Megan Ludwig, Anne Eaton, (unknown), (unknown), (unknown), (unknown), Gautam Jha, Ian J. Okazaki, Charles J. Ryan, Nicholas A. Zorko, Yingchun Zhao, Zuzan Caycı, Scott M. Dehm, Jiarong Hong, Peter W. Villalta, (unknown), Justin M. Drake, Emmanuel S. Antonarakis	0
3	Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients 2024 ·Cancers ·(unknown), Megan Ludwig, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yingchun Zhao, Scott M. Dehm, Zuzan Caycı, Justin H. Hwang, Peter W. Villalta, Emmanuel S. Antonarakis, Justin M. Drake	0
4	Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases 2024 ·npj Precision Oncology ·Megan Ludwig, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), John R. Lozada, (unknown), (unknown), (unknown), Scott M. Dehm, Paari Murugan, Justin H. Hwang, Justin M. Drake, Emmanuel S. Antonarakis	3
5	Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts 2024 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Megan Ludwig, (unknown), Ilsa M. Coleman, Eva Corey, Stephen R. Plymate, Peter S. Nelson, Justin H. Hwang, Justin M. Drake	4
6	CRABP1-complexes in exosome secretion 2024 ·Cell Communication and Signaling ·(unknown), (unknown), Megan Ludwig, Justin M. Drake, Li‐Na Wei	2
7	Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma 2023 ·Archives of Oral Biology ·Megan Ludwig, Nicole L. Michmerhuizen, (unknown), Andrew C. Birkeland, (unknown), (unknown), (unknown), (unknown), Aditi Kulkarni, Hui Jiang, Paul Swiecicki, J. Chad Brenner	1
8	ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems 2023 ·Communications Biology ·(unknown), (unknown), (unknown), Atef Ali, (unknown), (unknown), John R. Lozada, Xiaolei Shi, (unknown), Sean McSweeney, (unknown), Megan Ludwig, Emmanuel S. Antonarakis, Justin M. Drake, Scott M. Dehm, Charles J. Ryan, Jinhua Wang, Justin H. Hwang	4
9	Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene 2021 ·BMC Cancer ·Molly E. Heft Neal, Andrew C. Birkeland, (unknown), (unknown), Aditi Kulkarni, Susan K. Foltin, (unknown), Megan Ludwig, (unknown), Hui Jiang, Jonathan B. McHugh, (unknown), Erin L. McKean, J. Chad Brenner	10
10	Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana 2019 ·Health Science Reports ·(unknown), (unknown), Evelyn Jiagge, Ernest Adjei, Susan K. Foltin, Megan Ludwig, Jonathan B. McHugh, J. Chad Brenner, Sofía D. Merajver	8
11	The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines 2018 ·Oral Oncology ·Megan Ludwig, Aditi Kulkarni, Andrew C. Birkeland, Nicole L. Michmerhuizen, Susan K. Foltin, Jacqueline E. Mann, Rebecca C. Hoesli, Samantha N. Devenport, (unknown), Andrew G. Shuman, Matthew E. Spector, Thomas E. Carey, Hui Jiang, J. Chad Brenner	24
12	Abstract 814: NOTCH1 regulates head and neck cancer cell growth and invasion 2017 ·Cancer Research ·Andrew C. Birkeland, Megan Ludwig, Jacqueline E. Mann, Samantha N. Devenport, Rebecca C. Hoesli, (unknown), Matthew E. Spector, Carol R. Bradford, Thomas E. Carey, Mark E. Prince, J. Chad Brenner	1
13	Identification of TargetableERBB2Aberrations in Head and Neck Squamous Cell Carcinoma 2016 ·JAMA Otolaryngology–Head & Neck Surgery ·Andrew C. Birkeland, Megan Yanik, (unknown), (unknown), Susan K. Foltin, Jacqueline E. Mann, Nicole L. Michmerhuizen, Megan Ludwig, (unknown), Christine M. Komarck, Thomas E. Carey, Mark E. Prince, Carol R. Bradford, Jonathan B. McHugh, Matthew E. Spector, J. Chad Brenner	35
14	Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma. 2016 ·PubMed ·Megan Ludwig, Andrew C. Birkeland, Rebecca C. Hoesli, Paul Swiecicki, Matthew E. Spector, J. Chad Brenner	22
15	Genomic sequencing and precision medicine in head and neck cancers 2016 ·European Journal of Surgical Oncology ·Rebecca C. Hoesli, Megan Ludwig, Nicole L. Michmerhuizen, Andrew J. Rosko, Matthew E. Spector, J. Chad Brenner, Andrew C. Birkeland	10
16	Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma 2016 ·Cancer Biology and Medicine ·Megan Ludwig, Andrew C. Birkeland, Rebecca C. Hoesli, Paul Swiecicki, Matthew E. Spector, J. Chad Brenner	25
17	Nuclear localization signal sequence is required for VACM-1/CUL5-dependent regulation of cellular growth 2016 ·Cell and Tissue Research ·(unknown), (unknown), (unknown), (unknown), Megan Ludwig, (unknown), Steven P. Lewis, (unknown), Zachary J. DeBruine, (unknown), Maria A. Burnatowska-Hledin	13
18	The Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck Cancer 2015 ·Cancers ·Andrew C. Birkeland, Megan Ludwig, (unknown), J. Chad Brenner, Mark E. Prince	19
19	Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients 2001 ·European Journal of Clinical Pharmacology ·Philipp Lohmann, M. L. Rao, Megan Ludwig, (unknown), Ulrich M. Zanger, Klaus Mörike, W. Maier, M. Bagli	9
20	Haemophilia B: database of point mutations and short additions and deletions—fourth edition, 1993 1993 ·Nucleic Acids Research ·F. Giannelli, (unknown), Katherine A. High, (unknown), M.‐C. Poon, Megan Ludwig, R. Schwaab, P H Reitsma, (unknown), (unknown), G. G. Brownlee	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact